Biotechnology

CSL Limited

CSL.AX·ASX·Website

Latest price

—

Opened at: —
Today's high: —
Today's low: —
Company size: A$59.21B

How the price has moved

Loading…

What you need to know

We're putting together a quick summary…

Looking up the company

About CSL Limited

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Source: company filings via Yahoo Finance. Educational only — not investment advice.

Recent news about CSL.AX

What people are saying about the company

The basics

Quick reads on growth, price, and stability

Share price

—

How much the share price has gained over the last year. The 5-year average is the typical yearly return over the past 5 years.

Will it grow?

The signs that the business is getting bigger and more profitable

Sales growth
—
How much the company's total sales went up (or down) over the last year. We show the 5-year average alongside so you can see if growth is steady, speeding up, or slowing down.
Profit growth
—
How much the company's profit per share went up over the last year, with the 5-year average shown next to it. Profit growing faster than sales usually means the business is getting more efficient.
Profit margin
—
Out of every $100 of sales, how much the company keeps as profit. Higher means they have pricing power and aren't getting squeezed by costs.
How well they use the money
—
A different question from 'is it expensive?'. P/E asks how much YOU pay for the stock. This one asks how good the COMPANY is at turning shareholder money into profit. 15% means they squeeze $15 of profit a year out of every $100 of shareholder money sitting in the business.

Is the price fair?

Whether you're paying a reasonable amount for what you get

Is it expensive?
—
How many dollars investors pay for $1 of yearly profit. 20× means $20 today for $1 of profit a year. Lower is usually cheaper. Compare to growth — fast growers can earn higher P/E.
Year's range
—
The lowest and highest the share has traded over the past year. If today's price is near the high, the stock is priced for optimism; near the low, sentiment is gloomier.

Is it healthy?

How stable the company is — and whether shareholders get cash back

Debt vs ownership
—
How much the company owes (debt) compared to what the shareholders own (equity). Above 1.0 means more borrowed than owned — high debt makes a company more fragile when times get tough.
Cash back to investors
—
If the company pays cash to shareholders, how much per year as a % of price. 3% means $3/year for every $100 invested. Many growth companies pay nothing and reinvest instead.

How big is it?

Company size
—
What the whole company is worth — share price times every share. The headline 'price tag' of the business.

How they've been doing

Last four quarters · expected vs. actual earnings

Similar companies

Other stocks in the same neighbourhood